Showing results (971-980 of 2,505) with videos related to
Sort By:
Pageof 251
Journal of Diabetes Investigation|May 17, 2016
Berberine activates peroxisome proliferator-activated receptor gamma to increase atherosclerotic plaque stability in Apoe-/- mice with hyperhomocysteinemiaHongjun Li, Chengyan He, Jingying Wang, et al.Journal of Diabetes Investigation|May 17, 2016
Long-term safety and efficacy of a novel once-weekly oral trelagliptin as monotherapy or in combination with an existing oral antidiabetic drug in patients with type 2 diabetes mellitus: A 52-week open-label, phase 3 studyNobuya Inagaki, Hiroki Sano, Yoshifumi Seki, et al.Journal of Diabetes Investigation|May 17, 2016
Effects of ethanol extract of propolis on histopathological changes and anti-oxidant defense of kidney in a rat model for type 1 diabetes mellitusHamid Reza Sameni, Parisa Ramhormozi, Ahmad Reza Bandegi, et al.Journal of Diabetes Investigation|May 17, 2016
Different role of zinc transporter 8 between type 1 diabetes mellitus and type 2 diabetes mellitusBo Yi, Gan Huang, Zhiguang ZhouJournal of Diabetes Investigation|May 17, 2016
Randomized clinical trial of the safety and efficacy of sitagliptin and metformin co-administered to Chinese patients with type 2 diabetes mellitusLinong Ji, Ping Han, Xiaoyue Wang, et al.Journal of Diabetes Investigation|May 17, 2016
Single and multiple dose pharmacokinetics and pharmacodynamics of omarigliptin, a novel, once-weekly dipeptidyl peptidase-4 inhibitor, in healthy Japanese menSaori Tsuchiya, Evan Friedman, Carol Addy, et al.Journal of Diabetes Investigation|May 17, 2016
Association between interleukin-19 and angiopoietin-2 with vascular complications in type 2 diabetesLi Li, Yu ZHeng-Qing, Hu Juan-Yu, et al.Journal of Diabetes Investigation|May 17, 2016
Adherence to dipeptidyl peptidase-4 inhibitor therapy among type 2 diabetes patients with employer-sponsored health insurance in JapanKaren Kurtyka, Rie Nishikino, Chie Ito, et al.Journal of Diabetes Investigation|May 17, 2016
Urinary adiponectin and progression of diabetic nephropathy in type 1 diabetesKyoung Hwa Ha, Dae Jung KimJournal of Diabetes Investigation|May 17, 2016
Combination therapy with liraglutide and insulin in Japanese patients with type 2 diabetes: A 36-week, randomized, double-blind, parallel-group trialYutaka Seino, Shizuka Kaneko, Shuichi Fukuda, et al.Pageof 251